ISSN: 1546-9530

Journal Guideline

Current Heart Failure Reports Q1 Unclaimed

Current Science, Inc. United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Current Heart Failure Reports provides in-depth review articles contributed by international experts on the most significant developments in the field. By presenting clear, insightful, balanced reviews that emphasize recently published papers of major importance, the journal elucidates current and emerging approaches to the diagnosis, treatment, management, and prevention of heart failure and associated conditions. It has an SJR impact factor of 0,767.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Categories: Emergency Medicine (Q1) Cardiology and Cardiovascular Medicine (Q2) Physiology (medical) (Q2)

Price

3060 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

0,767

SJR Impact factor

45

H Index

43

Total Docs (Last Year)

113

Total Docs (3 years)

3558

Total Refs

370

Total Cites (3 years)

112

Citable Docs (3 years)

3.29

Cites/Doc (2 years)

82.74

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Circulation Q1
Nature Metabolism Q1
Sleep Medicine Reviews Q1
Circulation: Arrhythmia and Electrophysiology Q1
JACC: Clinical Electrophysiology Q1

Compare this journals

Aims and Scope

Best articles by citations

Does Cardiac Resynchronization Therapy Prevent Heart Failure?

Managing acute renal failure in patients with acute decompensated heart failure: The cardiorenal syndrome

Leveraging cardiac resynchronization therapy devices to monitor patients with heart failure

Acute Heart Failure: Patient Characteristics and Pathophysiology

Understanding the Epidemic of Heart Failure: Past, Present, and Future

The Value of Psychosocial Factors in Patient Selection and Outcomes after Heart Transplantation

Pharmacologic management of the cardiorenal syndrome in heart failure

Inhibiting the renin-angiotensin system with ACE inhibitors or ARBs after MI

Assessment of myocardial ischemia and viability using cardiac magnetic resonance

Current status of cardiac transplantation and mechanical circulatory support

Neuregulin as a Heart Failure Therapy and Mediator of Reverse Remodeling

Respiratory muscle function and exercise intolerance in heart failure

SHOW MORE ARTICLES

Role of Monitoring Devices in Preventing Heart Failure Admissions

Pharmacologic Strategies to Preserve Renal Function in Acute Decompensated Heart Failure

Novel Natriuretic Peptides: New Compounds and New Approaches

Is there a cardiomyopathy of obesity?

Current and novel cardiac support therapies

Cardiohepatic Syndrome

The Benefits of Revascularization in Chronic Heart Failure

The conundrum of ventricular arrhythmia and cardiomyopathy: Which abnormality came first?

Impact of Intravenous Nitroglycerin in the Management of Acute Decompensated Heart Failure

Current status of implantable cardioverter-defibrillator therapy in heart failure

Echocardiographic assessment of left ventricular relaxation and cardiac filling pressures

Cardiometabolic Disease Leading to Heart Failure: Better Fat and Fit Than Lean and Lazy